{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreieavqqlopwmccwohs747xh6m7fjhya4fiw3glwq744flukhqzyihu",
    "uri": "at://did:plc:7nuyhqvd4a6xquezhjhvregv/app.bsky.feed.post/3moehqisuo4p2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihkdoa5wf2d3qewkhxfjhju2yph2kjjenmp3xfd3lunili32bodem"
    },
    "mimeType": "image/jpeg",
    "size": 772873
  },
  "path": "/2026/06/15/us/politics/kratom-trump-administration.html",
  "publishedAt": "2026-06-15T21:09:17.000Z",
  "site": "https://www.nytimes.com",
  "tags": [
    "Regulation and Deregulation of Industry",
    "Lobbying and Lobbyists",
    "Drug Abuse and Traffic",
    "Addiction (Psychology)",
    "Drug Enforcement Administration",
    "Homeland Security Department",
    "Food and Drug Administration",
    "Kennedy, Robert F Jr",
    "Mullin, Markwayne",
    "DeWine, Mike",
    "Gottlieb, Scott (1972- )",
    "Makary, Marty",
    "Vance, J D",
    "kratom"
  ],
  "textContent": "With support from Markwayne Mullin and Robert F. Kennedy Jr., the kratom industry is pursuing a potentially lucrative policy. Mr. Mullin owns equity in a company that could benefit.",
  "title": "How Kratom, an Addictive Gas Station Drug, Found Allies in Trump’s Cabinet"
}